Abstract Library

Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.

Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.

ENETS Abstract Search

#2715 The Role of Serum Concentration Ratio of Neuron-Specific Enolase in the Evaluation of Therapeutic Effect of Neuroendocrine Tumor

Introduction: There has been no good serum biomarker for the evaluation of the therapeutic effect of Neuroendocrine tumors(NET)

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Jingbao K,

Keywords: Neuroendocrine tumor, NSE Ratio, Therapeutic effect, Progression-free survival,

#1857 Association between Neuroendocrine Tumors (NETs) Biomarkers and Tumor Burden Based on Total 68Ga-DOTATATE-Avid Tumor Volume (TV) Measurements

Introduction: No study has yet assessed the utility of biochemical biomarkers for evaluating NET burden using 68Ga-DOTATATE PET/CT.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Tirosh A, Papadakis G, Millo C, Sadowski S, Herscovitch P,

Keywords: PET burden,

#1517 Additional Value for Urinary 5-Hydroxyindoleacetic Acid as Prognostic Marker in Neuroendocrine Tumors?

Introduction: 5-Hydroxyindoleacetic Acid (5-HIAA) is of value for diagnosis of NETs and correlates with severity of carcinoid syndrome. However its value for determining prognosis is uncertain, particularly in combination with other biomarkers

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Zandee W

Authors: Zandee W, Kamp K, Van Adrichem R, Feelders R, De Herder W,

Keywords: prognosis 5-HIAA,

#1501 Inhibition of Intestinal Neuroendocrine Tumor by a New Marker of Normal Neuroendocrine Cells

Introduction: Although gastrointestinal neuroendocrine tumors are increasing worldwidely, few treatment options could be chosen

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Guo Y

Authors: Pan B, Yang W, Zhang T, Guo Y,

Keywords: GEP-NETs, Wnt, marker,

#1197 The Neuron-Specific Enolase Assessment in Patients with Neuroendocrine Tumors with or without Carcinoid Syndrome

Introduction: NeuroEndocrine Tumors (NETs) comprises a wide area of clinical presentations and neuroendocrine markers.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Carsote M, Capatina C, Terzea D, Petris R, Goldstein A,

Keywords: neuron-specific enolase, neuroendocrine tumors,